Apyx Medical (APYX) Interest Coverage Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.39% |
| Dec 31, 2025 | 604.79% |
| Sep 30, 2025 | 68.13% |
| Jun 30, 2025 | 16.66% |
| Mar 31, 2025 | -20.25% |
| Dec 31, 2024 | 27.41% |
| Sep 30, 2024 | 34.65% |
| Jun 30, 2024 | 17.97% |
| Mar 31, 2024 | 8.45% |
| Dec 31, 2023 | 34.70% |
| Sep 30, 2023 | -248.51% |
| Jun 30, 2023 | 90.51% |
| Mar 31, 2023 | 98.79% |
| Dec 31, 2022 | 65.80% |
| Sep 30, 2022 | -190.26% |
| Jun 30, 2022 | -171.44% |
| Mar 31, 2022 | 56.63% |
| Dec 31, 2021 | -27.92% |
| Sep 30, 2021 | 34.57% |
| Jun 30, 2021 | -70.41% |
| Mar 31, 2021 | -304.47% |
| Dec 31, 2020 | -67.75% |
| Sep 30, 2020 | 77.32% |
| Jun 30, 2020 | 38.26% |
| Mar 31, 2020 | -67.58% |
| Dec 31, 2018 | -3,039.35% |
| Sep 30, 2018 | -20.40% |
| Jun 30, 2018 | 3.52% |
| Dec 31, 2016 | 4,959.67% |
| Sep 30, 2016 | 99.40% |
| Jun 30, 2016 | -239.32% |
| Mar 31, 2016 | 217.41% |
| Dec 31, 2015 | -531.82% |
| Sep 30, 2015 | -73.57% |
| Jun 30, 2015 | 1,775.68% |
| Mar 31, 2015 | 125.18% |
| Dec 31, 2014 | 152.13% |
| Sep 30, 2014 | -211.64% |
| Jun 30, 2014 | 20,395.47% |